Article
APOE Genotype and Alzheimer Disease Risk Across Age, Sex, and Population Ancestry.
JAMA neurology - 1 Dec 2023
Belloy Michael E, Andrews Shea J, Le Guen Yann, Cuccaro Michael, Farrer Lindsay A, Napolioni Valerio, Greicius Michael D
Abstract excerpt
Importance: Apolipoprotein E (APOE)*2 and APOE*4 are, respectively, the strongest protective and risk-increasing, common genetic variants for late-onset Alzheimer disease (AD), making APOE status highly relevant toward clinical trial design and AD research broadly. The associations of APOE genotypes with AD are modulated by age, sex, race and ethnicity, and ancestry, but these associations remain unclear,...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
